NeuroOne Medical Technologies makes brain electrodes and nerve ablation systems for surgeons and pain specialists. NMTC reports earnings on Tue, Dec 15, 2026.
Earnings
Earnings calendar →Analyst Ratings & Price Targets
Analyst Ratings →| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| Aug 14 | Maxim Group | Maintained | Buy |
Seasonality
How NMTC has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2018.
Whale Options Flow
90DNo whale options trades in NMTC in the last 90 days.
AI Auto Pilots
Paper tradingStreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether NMTC is in one of them and how their past NMTC trades turned out.
Macro & Market News
All StreetAlpha news →StreetAlpha hasn't covered NMTC in an article yet. Here's the latest on the wider market.
About NEUROONE MEDICAL TECHNOLOGIES
NeuroOne Medical Technologies is a medical technology company based in Eden Prairie, Minnesota. It makes thin film electrodes that record and stimulate brain activity during surgery, along with radiofrequency ablation systems used to treat epilepsy and nerve pain. Its customers are mainly neurosurgeons, neurologists, pain management physicians and hospitals. The company is also developing spinal cord stimulation and drug delivery devices that are not yet sold.
- Headquarters
- Eden Prairie, MN